See below part of the announcement to market 30/03/2015 cancer...

See below part of the announcement to market 30/03/2015 cancer trial sucess. I believe this announcement was the one that made the sp jump to 4.5 c a while back. Rang a bell cos they refer to more than three times improvement when combined with cetuximab and
DocetaxelDocetaxel, one of which appears to be an existing chemo drug?

Perth, Australia March 30 2015: A pilot study by one of Australia’s leading breast
cancer experts, Associate Professor Pilar Blancafort, a member of the Harry Perkins
Institute of Medical Research, shows that Phylogica’s cell penetrating peptides
(CPPs) linked with the Omomyc drug kill aggressive drug resistant breast cancer
cells in vivo.
Professor Blancafort also observed that Phylogica’s CPP fusion significantly
improved the efficacy of existing anticancer drugs including the antibody Cetuximab
and the chemotherapy agent Docetaxel. For example, a combination of Cetuximab
and a Phylomer CPP-Omomyc fusion was more than three times more effective at
killing drug resistant breast cancer cells than either of these agents alone.
Associate Professor Blancafort commented: “The ability to combine drugs to treat
breast cancer is particularly exciting as it has the potential to lower the likelihood of
resistance, improve drug activity and reduce chemotherapy side-effects.”